Pathophysiology of myocardial reperfusion injury;Pathophysiologie des myokardialen reperfusionsschadens

Deutsche Medizinische Wochenschrift

Volumn 133, Issue 12, 2008, Pages 586-590

  Piper, H M ^a   Kasseckert, S A ^a   Schluter K D ^a   Abdallah, Y ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Calcium; Mitochondria; Myocardial infarction; Myocardial protection; Reperfusion injury

Indexed keywords

CALCIUM ION; CALCIUM;

CALCIUM CELL LEVEL; CYTOSOL; HEART CONTRACTION; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; MITOCHONDRION; NECROSIS; PATHOPHYSIOLOGY; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; CORONARY ARTERY BLOOD FLOW; HEART MITOCHONDRION; METABOLISM; METHODOLOGY; TREATMENT OUTCOME;

CALCIUM; CORONARY CIRCULATION; HUMANS; MITOCHONDRIA, HEART; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

EID: 41149083995     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1067290     Document Type: Review

References (51)

1. Abdallah Y, Gkatzoflia A, Pieper H et al. Mechanism of cGMP-mediated protection in a cellular model of myocardial reperfusion injury. Cardiovasc Res 2005; 66(1): 123-131
2. Abdallah Y, Gkatzoflia A, Gligorievski D et al. Insulin protects cardiomyocytes against reoxygenation-induced hypercontracture by a survival pathway targeting SR Ca2+ storage. Cardiovasc Res 2006; 70 (2): 346-53
3. Argaud L, Gateau-Roesch O, Raisky O, Loufouat J, Robert D, Ovize M. Postconditioning inhibits mitochondrial permeability transition. Circulation 2005; 111: 194-197
4. Baines CP, Kaiser RA, Purcell NH et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 2005; 434: 658-662
5. Bernardi P, Krauskopf A, Basso E et al. The mitochondrial permeability transition from in vitro artifact to disease target. FEBS J 2006; 273: 2077-2099
6. Bhamra GS, Hausenloy DJ, Davidson SM et al. Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening. Basic Res Cardiol, 2007 Dec 13[Epub ahead of print]
7. Bopassa JC, Ferrera R, Gateau-Roesch O, Couture-Lepetit E, Ovize M. PI 3-kinase regulates the mitochondrial transition pore in controlled reperfusion and postconditioning. Cardiovasc Res 2006; 69 (1): 178-185
8. Di Lisa F, Menabo R, Canton M, Barile M, Bernardi P. Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J Biol Chem 2001; 276: 2571-2575
9. Ganote CE. Contraction bands necrosis and irreversible myocardial injury. J Mol Cell Cardiol 1983; 15: 67-73
10. Garcia-Dorado D, Theroux P, Desco M et al. Cell-to-cell interaction: a mechanism to explain wave-front progression of myocardial necrosis. Am J Physiol 1989; 256; H1266-H1273
11. Garcia-Dorado D, Theroux P, Duran JM et al. Selective inhibition of the contractile apparatus. A new approach to modification of infarct size, infarct composition, and infarct geometry during coronary artery occlusion and reperfusion. Circulation 1992; 85: 1160-1174
12. Garcia-Dorado D, Gonzalez MA, Barrabes JA et al. Prevention of ischemic rigor contracture during coronary occlusion by inhibition of Na(+)-H+ exchange. Cardiovasc Res 1997; 35: 80-89
13. Garcia-Dorado D, Inserte J, Ruiz-Meana M et al. Gap junction uncoupler heptanol prevents cell-to-cell progression of hypercontracture and limits necrosis during myocardial reperfusion. Circulation 1997; 96: 3579-3586
14. Gomez L, Thibault H, Gharib A et al. Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice. Am J Physiol Heart Circ Physiol 2007; 293 (3): H1654-61
15. Griffiths EJ, Halestrap AP. Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J 1995; 307: 93-98
16. Halestrap AP, Clarke SJ, Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion - a target for cardioprotection. Cardiovasc Res 2004; 61: 372-385
17. Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res 2004; 61 (3): 448-460
18. Hausenloy DJ, Tsang A, Yellon DM. The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc Med 2005; 15: 69-75
19. Inserte J, Garcia-Dorado D, Ruiz-Meana M et al. Effect of inhibition of Na(+)/Ca(2+) exchanger at the time of myocardial reperfusion on hypercontracture and cell death. Cardiovasc Res 2002; 55: 739-748
20. Inserte J, Garcia-Dorado D, Hernando V, Soler-Soler J. Calpain-mediated impairment of Na+/K+-ATPase activity during early reperfusion contributes to cell death after myocardial ischemia. Circ Res 2005; 97: 465-473
21. Juhaszova M, Zorov DB, Kim SH et al. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 2004; 113 (11): 1535-1549
22. Kin H, Zhao ZQ, Sun HY et al. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res 2004; 62: 74-85
23. Kitakaze M, Asakura M, Shintani Y et al. Large-scale trial using natriuretic peptide or nicorandil as an adjunct to percutaneous coronary intervention for ST-segment elevation acute myocardial infarction. Circulation 2006; 114: 2425-2426
24. Kitakaze M, Asakura M, Kim J et al. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): Two randomised trials. Lancet 2007; 370 (9597): 1483-1492
25. Klein HH, Pich S, Bohle RM et al. Na(+)/H(+) exchange inhibitor cariporide attenuates cell injury predominantly during ischemia and not at onset of reperfusion in porcine hearts with low residual blood flow. Circulation 2000; 102: 1977-1982
26. Kuga H, Ogawa K, Oida A et al. Administration of atrial natriuretic peptide attenuates reperfusion phenomena and preserves left ventricular regional wall motion after direct coronary angioplasty for acute myocardial infarction. Circ J 2003; 67: 443-448
27. Ladilov YV, Siegmund B, Piper HM. Protection of reoxygenated cardiomyocytes against hypercontracture by inhibition of Na+/H+ exchange. Am J Physiol 1995; 268: H1531-H1539
28. Ladilov Y, Haffner S, Baiser-Schäfer C, Maxeiner H, Piper HM. Cardioprotective effects of KB-R7943: a novel inhibitor of the reverse mode of Na+/Ca2+ exchanger. Am J Physiol 1999; 276: H1868-76
29. Ladilov Y, Efe O, Schäfer C et al. Reoxygenation-induced rigor-type contracture. J Mol Cell Cardiol 2003; 35: 1481-1490
30. Lim SY, Davidson SM, Hausenloy DJ, Yellon DM. Preconditioning and post-conditioning: the essential role of the mitochondrial permeability transition pore. Cardiovasc Res 2007; 75 (3): 530-535
31. Liu J, Marchase RB, Chatham JC. Increased O-GlcNAc levels during reperfusion lead to improved functional recovery and reduced calpain proteolysis. Am J Physiol Heart Circ Physiol 2007; 293 (3): H1391-9
32. Ma X, Zhang X, Li C, Luo M. Effect of postconditioning on coronary blood flow velocity and endothelial function and LV recovery after myocardial infarction. J Interv Cardiol 2006; 19 (5): 367-375
33. Nakagawa T, Shimizu S, Watanabe T et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 2005; 434: 652-658
34. Nichols CG, Lederer WJ. The role of ATP in energydeprivation contractures in unloaded rat ventricular myocytes. Can J Physiol Pharmacol 1990; 68: 183-194
35. Park SS, Zhao H, Mueller RA, Xu Z. Bradykinin prevents reperfusion injury by targeting mitochondrial permeability transition pore through glycogen synthase kinase 3beta. J Mol Cell Cardiol 2006; 40 (5): 708-16
36. Piper HM, Kasseckert S, Abdallah Y. The sarcoplasmic reticulum as the primary target of reperfusion protection. Cardiovasc Res 2006; 70: 170-173
37. Piper HM, Abdallah Y, Kasseckert S, Schlüter KD. Sarcoplasmic reticulum mitochondrial interaction in the mechanism of acute reperfusion injury. Cardiovasc Res, 2007 Dec 18[Epub ahead of print]
38. Rodriguez-Sinovas A, Abdallah Y, Piper HM, Garcia-Dorado D. Reperfusion injury as a therapeutic challenge in patients with acute myocardial infarction. Heart Fail Rev 2007; 12: 207-216
39. Ruiz-Meana M, Garcia-Dorado D, Hofstaetter B, Piper HM, Soler-Soler J. Propagation of cardiomyocyte hypercontracture by passage of Na+ through gap junctions. Circ Res 1999; 85: 280-287
40. Rupprecht HJ, vom Dahl J, Terres W et al. Cardioprotective effects of the Na(+)/H(+) exchange inhibitor cariporide in patients with acute anterior myocardial infarction undergoing direct PTCA. Circulation 2000; 101: 2902-2908
41. Schäfer C, Ladilov Y, Inserte J et al. Role of the reverse mode of the Na+/Ca2+ exchanger in reoxygenation-induced cardiomyocyte injury. Cardiovasc Res 2001; 51: 241-250
42. Schinzel AC, Takeuchi O, Huang Z et al. Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc Natl Acad Sci USA 2005; 102: 12005-12010
43. Schlack W, Uebing A, Schäfer M et al. Regional contractile blockade at the onset of reperfusion reduces infarct size in the dog heart. Pflugers Arch 1994; 428: 134-141
44. Sebbag L, Verbinski SG, Reimer KA, Jennings RB. Protection of ischemic myocardium in dogs using intracoronary 2,3-butanedione monoxime (BDM). J Mol Cell Cardiol 2003; 35: 165-176
45. Siegmund B, Klietz T, Schwartz P, Piper HM. Temporary contractile blockade prevents hypercontracture in anoxic-reoxygenated cardiomyocytes. Am J Physiol 1991; 260: H426-H435
46. Siegmund B, Schlack W, Ladilov YV, Balser C, Piper HM. Halothane protects cardiomyocytes against reoxygenation-induced hypercontracture. Circulation 1997; 96: 4372-4379
47. Staat P, Rioufol G, Piot C et al. Postconditioning the human heart. Circulation 2005; 112: 2143-2148
48. Theroux P, Chaitman BR, Danchin N et al. Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemic against necrosis (GUARDIAN) Investigators. Circulation 2000; 102: 3032-3038
49. Yin H, Chao L, Chao J. Adrenomedullin protects against myocardial apoptosis after ischemia/reperfusion through activation of Akt-GSK signaling. Hypertension 2004; 43 (1): 109-116
50. Zeymer U, Suryapranata H, Monassier JP et al. The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial. J Am Coll Cardiol 2001; 38: 1644-1650
51. Zhao ZQ, Corvera JS, Halkos ME et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003; 285 (2): H579-88 Erratum in: Am J Physiol Heart Circ Physiol 2004 Jan; 286(1): H477